Roivant Sciences (ROIV) Change in Account Payables (2020 - 2025)

Roivant Sciences' Change in Account Payables history runs 6 years deep, the most recent figure standing at -$12.7 million for Q4 2025.

• Quarterly Change in Account Payables rose 29.25% year-over-year to -$12.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$39.5 million (down 15.25% YoY) and the FY2026 annual result came in at $3.4 million, up 118.81% from the prior year.
• Change in Account Payables was -$12.7 million for Q4 2025 at Roivant Sciences, down from $3.0 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $62.9 million in Q3 2021 and bottomed at -$25.3 million in Q2 2024.
• A 5-year average of $2.4 million and a median of $1.8 million in 2023 frame the typical range for Change in Account Payables.
• Peak annual rise in Change in Account Payables reached 501.0% in 2024, while the deepest fall reached 1101.84% in 2024.
• Roivant Sciences' Change in Account Payables stood at $3.7 million in 2021, then surged by 278.28% to $14.0 million in 2022, then sank by 87.14% to $1.8 million in 2023, then plunged by 1101.84% to -$18.0 million in 2024, then gained by 29.25% to -$12.7 million in 2025.
• Business Quant data shows ROIV's Change in Account Payables at -$12.7 million in Q4 2025, $3.0 million in Q3 2025, and -$11.7 million in Q2 2025.